Maralixibat
MRX-701
Phase 2 small_molecule completed
Quick answer
Maralixibat for Biliary Atresia is a Phase 2 program (small_molecule) at Mirum Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mirum Pharmaceuticals
- Indication
- Biliary Atresia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed